Equity Transaction Chart
Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Equity Commentary
Equity Raises:
- On November 25, 2024, Decibel Cannabis Company (DB: TSX)(DBCCF: OTCQB) announced the closing of a $.84M Second Tranche Closing of a Non-Brokered Private Placement.
- The company sold 19.65M shares at $.043. The net price represented a discount of 14% from pre-announcement prices.
- The transaction pricing implies a .64x multiple of annualized revenues and a 3.67x multiple of consensus 2024 EBITDA.
Public vs. Private Raises:
- Both of the week’s capital raises were public and trade in the U.S. on OTC and in Canada (one on TSX and one on CSE).
Equity vs. Debt Cap Raises:
- Equity accounted for 99% of the week’s funds raised.
Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.